Study Comparing Remission Rates, in Patients With Major Depressive Disorder (MDD) (B2411003)

Pfizer

Status: Completed

Conditions: Major Depressive Disorder

Treatments: Other: Cohort

Study type: Observational

Funder types: Industry

Identifiers

NCT00770289

0600B-102374

B2411003 (Other Identifier)

Details and patient eligibility

About

Tools known as 'depression scales 'are widely used as assessments to evaluate a patient's response to treatment. The purpose of this study is the evaluation of the remission rates for patients with MDD. The evaluation will involve the use of HAM-D 17, and HAM-D 7 questionnaires and the comparison of those questionnaires.

Full description

12 weeks random

Enrollment: 851 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Outpatients
• 18-75 years old
• Patients diagnosed with MDD according to DSM IV without psychotic symptoms
• HAM-D17 > or = 18 on inclusion
• Patients receiving treatment for the first time or changing treatment based on their doctor's decision

Exclusion criteria

• Subjects with potentially problematic compliance
• Subjects participating in an interventional trial within the last 3 months

Trial design

851 participants in 1 patient group

Single group

Treatment:

Other: Cohort